Everyday health
Living every day with COPD
Over 1.4 million Australians are living with Chronic Obstructive Pulmonary Disease, or COPD, with as many as one in 20 people over the age of 55 affected by the condition. Although understanding of COPD has improved significantly in recent years, we are constantly seeking new avenues to explore in our relentless pursuit for better breathing.
How we do business
Pulling back the curtain on the PBS
GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.
Everyday health
Digital healthcare attitudes in Australia
How we do business
PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines
The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.
Access to healthcare
No 'silver bullet' to tackle this disease
Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.
Innovation
Bioelectronics
GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.
Access to healthcare
Giving babies a healthier start
Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?
Our people
Isaac Barr
Isaac Barr joined GSK as a chemical engineer graduate in 2015. Here he talks about his first year at our Boronia manufacturing plant supporting the team to build a new pilot vaccine facility.
How we do business
Open source: the future of medical discovery
There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.
How we do business
Crowd sourcing new treatments for malaria
New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.
Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Access to healthcare
A rapid response to slow acting disasters
GSK is working together with Save the Children and the Department of Foreign Affairs and Trade in Australia, to support the establishment of a new Emergency Health Unit EHU which can respond to natural disasters such as hurricanes and earthquakes, and provide essential healthcare during slow-acting disasters like malnutrition.
How we do business
Fostering excellence in respiratory research
GSK has been a significant supporter of The George Institute for Global Health for a number of years and we’ve recently contributed $161,000 to support a research fellow in respiratory medicine.
Environment
Reducing our carbon footprint
Reducing our carbon footprint while addressing health access in neighbouring, less developed countries.
Our Community
Volunteering in Kenya
Through GSK’s PULSE Volunteer Partnership, our employees can use their professional skills to help create sustainable change for our non-profit partners and the communities they serve.
Our Community
Victoria Police - Trek of a lifetime
We have been a long-standing supporter of the Victoria Police Kokoda Project, supporting the initiative since it began in 2007.
Our Community
Polio Australia - support of polio retreat to help those affected
Polio is a disease that has virtually been forgotten by our community. Although vaccination implemented in Australia in the late 1950s has prevented new infections, polio survivors form the largest single physical disability group in the country.
Everyday health
Every breathe you take: Alannah's story
Most of us take breathing for granted. It’s an automatic activity that we don’t need to think about. But imagine if every breath you took was a struggle; imagine waking up in the night wheezing and short of breath.
Our Community
Employees helping communities
Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.
Our people
Mark Lambert
Mark Lambert works in customer service and logistics, managing the process from customer order through to delivery at the customer’s door.
Our people
Lisa Bonadonna
Australian Lisa Bonadonna lives in Europe heading up GSK's global partnership with Save the Children.
Our people
Laura Ljubanovic
Laura talks about her experience stepping up from legal counsel to Head of the Legal Department at GSK Australia on International Women's Day 2016.
Our people
Rachael’s Trek for Kids
Rachael Bradley from our Consumer Healthcare team explains what she loves about building brand love for Panadol and why GSK is a great place to work.
Access to healthcare
International collaboration seeks to make childbirth safer in developing countries
A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries
Our Community
A comic book on vaccines
Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.
Our Community
Save the Children
GSK and Save the Children have the goal of helping to save the lives of one million children by sharing medical and humanitarian expertise.